Literature DB >> 17108860

Medicines for hypertension: changes to the UK NICE guidelines.

Sarah Ransome1, Jan Gower.   

Abstract

New NICE guidance on the use of medicines for hypertension, published in June 2006, will prompt a major review of treatment for those already receiving medication and also sets out a new treatment pathway for the newly diagnosed. The major change in the guidelines is in the status of beta blockers, which are no longer to be used as a routine treatment for hypertension. The guidelines provide a consensus on treatment, and nurses and their patients now have a clear and straightforward algorithm to follow. It is envisaged that these changes to the way medicines are prescribed for hypertension will have a significant impact on the number of people reaching their target blood pressure, and therefore the number of cardiovascular events occurring each year.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108860     DOI: 10.12968/bjon.2006.15.16.21853

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

1.  [semFYC therapeutic guidelines in primary care. Essential Arterial Hypertension Section: Updated? Evidence based?].

Authors:  José Abellán Alemán; Mariano Leal Hernández; Antonio Martínez Pastor; José García-Galbis Marín
Journal:  Aten Primaria       Date:  2009-03-21       Impact factor: 1.137

Review 2.  Olmesartan medoxomil: a review of its use in the management of hypertension.

Authors:  Lesley J Scott; Paul L McCormack
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.